期刊文献+

高血压合并良性前列腺增生症患者症状评分与血压节律变化之间的关系 被引量:5

Hypertension merger benign prostatic hyperplasia patient symptom score and between blood pressure rhythm change relations
下载PDF
导出
摘要 目的:观察高血压合并良性前列腺增生症患者症状评分与血压节律之间的关系。方法:连续选择74例高血压合并良性前列腺增生症患者,入选者治疗前接受国际前列腺症状评分量表(IPSS)评估和无创自动血压心电监测系统检查。结果:74例高血压合并良性前列腺增生症患者IPSS总分平均为(15.82±3.27)分。高总分组(41例,≥15.82分)的年龄、高血压病史、高血压分期和分级、日间收缩压、日间舒张压、夜间收缩压、夜间舒张压均明显高于低总分组(33例,<15.82分)(P均<0.01~0.05)。结论:前列腺症状评分可明显影响到高血压合并良性前列腺增生症患者的病情和血压变化。 Objective:Obeserve hypertension merger benign prostatic hyperplasia patient symptom score and between blood pressure rhythm change relations.Methods:A total of 74 patients with hypertension and benign prostatic hyperplasia were selected and evaluated in accordance with International Prostate Symptom Score(IPSS) and non-invasive automatic blood pressure monitoring system.Results:The average IPSS score was 15.82±3.27.Symptom scores,including average age,history of hypertension,average staging and grading of hypertension,mean daytime systolic pressure,mean daytime diastolic pressure,mean nighttime systolic pressure,and mean nighttime diastolic pressure,in the high-scored group(n=41,≥15.82) were significantly higher than those in the low-scored group(n=33,15.82;P 0.01~0.05).Conclusion:Scores of prostate could obviously affect illness condition and blood pressure changes among patients with hypertension and benign prostatic hyperplasia.
作者 宋宏新
出处 《中国民康医学》 2011年第6期661-661,781,共2页 Medical Journal of Chinese People’s Health
关键词 原发性高血压 良性前列腺增生症 国际前列腺症状评分 无创自动血压监测 Essential hypertension Benign prostatic hyperplasia International Prostate Symptom Score Non-invasive automatic blood pressure monitoring
  • 相关文献

参考文献3

二级参考文献46

  • 1李培军,张祥华,郭利君,那彦群.高血压对良性前列腺增生细胞增殖与凋亡的影响[J].中华男科学杂志,2005,11(2):94-97. 被引量:31
  • 2马勋龙,陶明德,王金松,李丽玲.爱普列特治疗老年良性前列腺增生症疗效观察[J].现代医药卫生,2007,23(2):174-175. 被引量:3
  • 3Meigs JB, Mohr B, Barry MJ, et al. J Clin Epidemol 2001; 54(9): 935-944.
  • 4Maruenda J, Bhatnagar V, Lowenthal DT. Urology 1999; 53(3 Suppl 3a) : 7-12: discussion 12-13, 41-42.
  • 5Hammarsten J, Hogstedt B. Eur Urol 2001; 39(2): 151- 158.
  • 6Golomb E, Rosenzweig N, Eilam R, et al. JAndrol 2000; 21(1): 58-64.
  • 7Nassis L, Frauman AG, Ohishi M, et al. J Pathol 2001; 195(5): 571-578.
  • 8Yokoyama M, Hiwada K, Kokubu T, et al. Clin Chim Acta 1980; 100(3): 253-258.
  • 9Van Sande ME, Scharpe SL, Neels HM, et al. Clin Chim Acta 1985; 147(3): 255-260.
  • 10Dinh DT, Frauman AG, Somers GR, et al. J Pathol 2002; 196(2): 213-219.

共引文献62

同被引文献29

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部